Assessment of Omentin-1 in diabetic nephropathy and Insulin Resistance individuals in type 2 diabetic patients
Maaen Journal for Medical Sciences · 17.01.2025 · 4 (1)
DOI: 10.55810/2789-9136.1068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Maaen Journal for Medical Sciences, online erschienen am 17.01.2025. Verfasst von Nabaa Najam. Abd zaid Alshamiry und 1 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
A case-control study at AL-Sadar Teaching Hospital/Al-Najaf Center found a negative correlation between serum omentin-1 levels and diabetic nephropathy, suggesting early detection of microvascular complications. Long-term diabetes increases the risk of complications, including nephropathy, which worsens over time. High blood pressure is a common comorbidity among diabetics, and careful glycemic control is necessary in advanced stages. Omentin-1 plays a role in enhancing insulin sensitivity and glucose metabolism, but further investigation is needed to determine diabetic nephropathy severity in T2DM patients.
Zitieren
APA
Alshamiry, N. N. A. Z., & Al-Ghuraibawi, N. H. A. (2025). Assessment of Omentin-1 in diabetic nephropathy and Insulin Resistance individuals in type 2 diabetic patients. Maaen Journal for Medical Sciences, 4(1). https://doi.org/10.55810/2789-9136.1068
Vancouver
Alshamiry NNAZ, Al-Ghuraibawi NHA. Assessment of Omentin-1 in diabetic nephropathy and Insulin Resistance individuals in type 2 diabetic patients. Maaen Journal for Medical Sciences. 2025;4(1). doi:10.55810/2789-9136.1068
BibTeX
@article{Alshamiry2025,
author = {Alshamiry, Nabaa Najam. Abd zaid and Al-Ghuraibawi, Nibras Hussain. Abdulsada},
title = {Assessment of Omentin-1 in diabetic nephropathy and Insulin Resistance individuals in type 2 diabetic patients},
journal = {Maaen Journal for Medical Sciences},
year = {2025},
volume = {4},
number = {1},
doi = {10.55810/2789-9136.1068}
}
EUVIMED